We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The U.S. Department of Health and Human Services' Office for the Assistant Secretary for Preparedness and Response has awarded an R&D contract to Cerus with a base value of ~$15M and maximum value of ~$201M if all options are exercised.
Cerus Corporation announced today that the Community Blood Center (CBC) in Appleton, Wisconsin has received a US Food and Drug Administration (FDA) approved biologics permit application (BLA)
Cerus Corporation (today reported that the company successfully achieved its primary efficacy and safety endpoint in the Phase III transfusion study of chronic anemia